[研究报告] 血浆治疗市场规模预计将从 2022 年的 3.9025 亿美元增长到 2030 年的 10.9764 亿美元;预计 2022 年至 2030 年市场复合年增长率为 13.80%。
分析师观点
血浆疗法市场分析解释了增长动力,例如人群中骨科疾病病例的增加,尤其是老年人群;运动员关节和肌肉损伤数量增加,以及对微创美容手术的需求激增。此外,根据患者需求定制血浆疗法预计将在 2022-2030 年期间为市场带来新趋势。
血浆疗法,也称为富血小板血浆 (PRP) 疗法,是指利用从成功康复的患者身上获得的血浆来治疗各种疾病并促进愈合过程。PRP 疗法可用于骨科治疗关节损伤、皮肤科皮肤复原手术以及牙科组织修复。PRP 中的生长因子可有效刺激组织再生,从而加速损伤愈合或增强美容手术的机制。
市场洞察
骨科疾病和肌肉损伤病例的增加以及 PRP 在美容手术中的应用增加推动了血浆治疗市场的发展
根据世界卫生组织 (WHO) 2023 年发布的统计数据,2019 年全球约有 5.28 亿人患有骨关节炎 (OA),自 1990 年以来增长了 113%。2020 年 12 月在 PubMed Central 上发表的一篇文章指出,PRP 的使用为组织修复提供了潜力,因为这种血浆中含有丰富的生长因子和细胞因子,这对于启动和调节软组织和硬组织的再生微环境至关重要。PRP 疗法可用于骨折的愈合;韧带、肌肉和肌腱损伤;周围神经损伤;关节软骨病变;以及骨关节炎。因此,骨科和组织修复手术对血浆疗法的需求很高。
此外,PRP 还用于整容手术,用于皮肤嫩肤、抗衰老和其他美容手术。2021 年 11 月在 PubMed Central 发表的一篇综述评估了 73 项研究,其中 45 项研究侧重于 PRP 单一疗法,而 35 项研究调查了 PRP 与微针联合使用的效果。因此,这些疗法耐受性良好,适用于所有光型。在各种情况下都发现了积极的治疗结果,包括皮肤嫩肤、疤痕修复、脱发、色素沉着、硬化性苔藓、麻风病引起的周围神经病变、斑块性银屑病和指甲疾病。
因此,PRP 在整容手术中的应用促进了血浆疗法市场的增长。
未来趋势
引入以患者为中心的治疗方案的定制化选择成为血浆治疗市场的未来趋势
定制血浆疗法是指根据患者的具体医疗状况和基因构成等因素,对血浆疗法进行个性化,以满足患者的需求。定制工作侧重于通过定制抗体和蛋白质等成分的组成来提高血浆疗法的疗效,从而更有效地治疗患者的特定健康状况。研究人员和医疗保健专业人士正在运用他们的专业知识,想出针对特定疾病(如自身免疫性疾病、传染病和罕见癌症类型)定制血浆疗法的方法。Regenexx 和 Bridging Biosciences 等公司提供高纯度和浓缩的 PRP,可定制以消除组织损伤愈合和细胞再生的不一致性。德克萨斯州的美国医学研究所提供 PRP TruDose 疗法,该疗法包含个性化治疗剂量,用于治疗肌肉骨骼疾病、狼疮、食物敏感性、莱姆病和许多退行性疾病的各种慢性疼痛。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围
基于类型的洞察
根据类型,血浆治疗市场细分为纯 PRP、富含白细胞的 PRP、纯富含血小板的纤维蛋白和富含白细胞的纤维蛋白。纯富含血小板的纤维蛋白细分市场在 2022 年占据了最大的市场份额,预计在 2022-2030 年期间的复合年增长率最高。富含白细胞的 PRP (LR-PRP) 是一种中性粒细胞 (白细胞) 浓度高于基线水平的 PRP。它通常与促炎作用有关。然而,在某些情况下,LR-PRP 可能有助于刺激体内炎症,以指示肌腱病等慢性疾病。
基于来源的洞察
根据来源,血浆治疗市场分为自体血浆和异体血浆。2020 年,自体血浆占据了市场主导地位。
基于应用的洞察
根据应用,血浆治疗市场分为骨科疾病、皮肤病、牙科疾病等。2022 年,皮肤病学领域占据了最大的市场份额。
基于最终用户的洞察
就最终用户而言,血浆治疗市场分为医院和诊所、研究机构、门诊手术中心 (ASC) 等。医院部门在 2022 年占据了最大的市场份额,预计在 2022-2030 年期间将实现最高的复合年增长率。
血浆治疗市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响血浆治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的血浆治疗市场细分和地理位置。
- 获取血浆治疗市场的区域特定数据
血浆治疗市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 3.9025亿美元 |
2030 年市场规模 | 10.9764亿美元 |
全球复合年增长率(2022 - 2030 年) | 13.80% |
史料 | 2020-2022 |
预测期 | 2022-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
血浆疗法市场参与者密度:了解其对业务动态的影响
血浆治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在血浆治疗市场运营的主要公司有:
- 生物测试
- CSL有限公司
- 基立福
- 凯德利翁公司
- 中国生物制品有限公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解血浆治疗市场的主要参与者概况
区域分析
2022 年,北美主导了血浆治疗市场。预计在 2022-2030 年期间,北美市场将创下最高复合年增长率。北美市场分为美国、加拿大和墨西哥。美国在全球血浆治疗市场中占有最大市场份额。该国市场的增长归因于骨科和整容手术中富血小板血浆 (PRP) 的迅速采用、医疗保健领域的投资不断增加、动态研发格局以及美国食品药品监督管理局对部分 PRP 疗法的批准。
报告介绍了全球血浆治疗市场的主要参与者。其中包括 BioLife Plasma Services;武田制药有限公司;Biotest AG CSL Ltd.;Grifols, SA;Kedrion SpA;ImmunoTek Bio Centers;Bio Products Laboratory Ltd.;中国生物制品控股有限公司;Octapharma AG;和 Origin, Inc. 这些领先企业专注于扩大和多样化其市场影响力和客户群,从而挖掘现有的商业机会。
主要市场参与者的关键发展包括:
- 2023 年 3 月,BioLife Plasma Services 宣布在美国开设血浆捐献中心,新地点位于马萨诸塞州西斯普林菲尔德和德克萨斯州皮尔兰。此次扩张将有助于该公司扩大业务网络。
- 2021 年 2 月,Atlas Health Medical Group 推出了 SkinPen。这款小型笔形微针设备含有用于面部拉皮的 PRP,可刺穿皮肤并刺激抗衰老反应。
- 2020 年 3 月,武田药品工业株式会社开始开发抗 SARS-CoV-2 多克隆高免疫球蛋白 (H-Ig),用于治疗患有严重 COVID-19 的患者。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The plasma therapy market majorly consists of the players such include BioLife Plasma Services; Takeda Pharmaceutical Company Limited; Biotest AG CSL Ltd.; Grifols, S.A.; Kedrion S.p.A; ImmunoTek Bio Centers; Bio Products Laboratory Ltd.; China Biologic Products Holdings, Inc.; Octapharma AG; and Origin, Inc.
Global plasma therapy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the plasma therapy market in 2022.
The CAGR value of the plasma therapy market during the forecasted period of 2020-2030 is 13.80%.
Plasma therapy entails the utilization of the blood plasma obtained from individuals who have successfully recovered from an illness to address the range of medical conditions and foster the process of healing. PRP treatments find applications in orthopedics for the treatment of joint injuries, dermatology in skin rejuvenation procedures, and dentistry for tissue repair. The growth factors present in PRP effectively stimulate the regeneration of tissues, thereby expediting the healing of injuries or enhancing mechanisms involved in aesthetic procedures.
The orthopedic conditions segment dominated the global plasma therapy market and held the largest market share of 35.31% in 2022.
The rising cases of orthopedic disorders in people, especially in the geriatric population; rising number of joint and muscle injuries in athletes, and surging demand for minimally invasive cosmetic procedures.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Plasma Therapy Market
- Biotest
- CSL Ltd.
- Grifols
- Kedrion S.p.A
- China Biologics, Inc.
- Octapharma
- Cambrin Biologics
- LFB SA
- Biolife Plasma Services
- China Biologics Products
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.